NEW:  Colorado State University embarking on follow up dose finding study of cannabidiol in dogs with intractable epilepsy.  For more information or to enroll:


Researchers at the Warsaw Zoo in Poland have launched a project to check whether cannabis-extract oil will reduce anxiety in the zoo's elephants. For more information:


CannPal announces completion of its safety and efficacy study on Dermacann®, which reduces atopic dermatitis symptoms in dogs.  For more information:

For preliminary results, see the announcement freely accessible online by clicking the link in the above press release, or directly below:


NEW: Tarleton State University’s Equine Center, part of the Texas A & M University system, seeks to quantify how CBD affects inflammation, stress and stereotypical negative behaviors in horses.  For more information:


University of Saskatchewan's Western College of Veterinary Medicine will undertake research to study whether cannabis can be used to prevent chronic vomiting in dogs and cats.  For more information:


University of Guelph will undertake a three-year study exploring the efficacy of cannabis for treating bladder cancer in dogs.  For more information:


CannPal progressing canine cannabinoid trials.  (Phase 2A pilot dose determination study for canine osteoarthritis and DermaCann trial starting soon.) For more information:


Penn Vet to study hemp-based supplement. For more information:


Canopy Growth announces clinical trial approval for the use of cannabis to treat anxiety in certain animals.  For more information:

CannPal Animal Therapeutics commences Phase 1B of the Pharmacokinetic and Safety study for CPAT-01D, a cannabis-derived pain control for dogs.  For more information:

*Click this link for a press release regarding preliminary results on this study. (At the bottom, there is a freely accessible link to the results presentation and research abstract from the 2019 Australian Veterinary Association)